Longitudinal study of the levodopa motor response in Parkinson's disease: Relationship between cognitive decline and motor function

Movement Disorders

Volumn 24, Issue 16, 2009, Pages 2337-2343

  Alty, Jane E ^a   Clissold, Benjamin G ^a   McColl, Craig D ^a   Reardon, Katrina A ^a   Shiff, Mark ^a   Kempster, Peter A ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Dementia; Dyskinesia; Levodopa; Motor fluctuation; Parkinson's disease

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CABERGOLINE; ENTACAPONE; LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; DYSKINESIA; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; LEWY BODY; LONGITUDINAL STUDY; MALE; MORTALITY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; COGNITION DISORDERS; DEMENTIA; DISABILITY EVALUATION; DYSKINESIAS; FEMALE; HUMANS; LEVODOPA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY; PARKINSONIAN DISORDERS; STATISTICS, NONPARAMETRIC;

EID: 73949135667     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22800     Document Type: Article

References (16)

1. Reardon KA, Shiff M, Kempster PA. Motor fluctuations in Parkinson's disease: a longitudinal study over 6 years. Mov Disord 1999; 14:605-611.
2. McColl CD, Reardon KA, Shiff M, Kempster PA. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease. Mov Disord 2002;6:1227-1234.
3. Clissold BG, McColl CD, Reardon KA, Shiff M, Kempster PA. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease. Mov Disord 2006;21:2116-2121.
4. Kempster PA, Frankel JP, Bovingdon M, Webster R, Stern GM, Lees AJ. Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989;52:718-723.
5. Folstein MF, Folstein SE, Mchugh PR. '"Mini-mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-198.
6. Schrag A, Dodel R, Spotke A, Bornschein B, Siebert U, Quinn N. Rate of clinical progression in Parkinson's disease. A prospective study. Mov Disord 2007;22:938-945.
7. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001;16:448-458.
8. Braak H, Müller CM, Rüb U, et al. Cognitive status correlates with neuropathological stage in Parkinson's disease. Neurology 2005;64:1404-1410.
9. Williams-Gray CH, Foltynie T, Brayne CEG, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinsons's disease cohort. Brain 2007;130:1787-1798.
10. Jankovic J, Kapadia AS. Functional decline in Parkinson's disease. Arch Neurol 2001;58:1611-1615.
11. Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression of parkinsonian signs in Parkinson's disease. Arch Neurol 1999;56:334-337.
12. Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Progression of motor impairment in Parkinson's disease. A population-based study. Neurology 2005;65:1436-1441.
13. Goetz CG, Stebbins GT, Blasucci LM. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Mov Disord 2000;15:479-484.
14. Nutt JG, Carter JH, Lea ES, Sexton GJ. Evolution of the response to levodopa during the first four years of therapy. Ann Neurol 2002;51:686-693.
15. Blin J, Dubois B, Bonnet AM, Vidailhet M, Branabur M, Agid Y. Does ageing aggravate parkinsonian disability. J Neurol Neurosurg Psychiatry 1991;54:780-782.
16. Hely MA, Morris JGL, Reid WGJ, Trafficante R. Sydney multicentre study of Parkinson's disease: non L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-199.